Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CPR Wolff Puzzles > Thromboembolic Drugs > Flashcards

Thromboembolic Drugs Flashcards

1
Q

Reason for selecting heparin (i.e. due to its inability to cross membrane barriers) as anticoagulant rather than warfarin)

A

Pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Doing this near eye, brain, or spinal cord is a contraindication for anticoagulants

A

Surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Can be used to measure anticoagulation for drugs such as rivaroxaban; not in notes but a version of this is not now also used to measure unfractionated heparin and low molecular weight heparin

A

Antixa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Recombinant human form purified from goat’s milk is available for those with deficiency, but it is expensive

A

Antithrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Substrate for plasmin

A

Fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Vitamin K-dependent anti-clotting factor with shorter half-life than several other factors, its disappearance is reason warfarin administration can cause a pro-coagulant phase

A

Protein C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Indication for alteplase, especially when within 3-6 hours and option of percutaneous coronary intervention is unavailable

A

Acute myocardial infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Indication for rivaroxaban or dabigatran

A

Nonvalvular atrial fibrillation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Indication for GP IIb/IIIa inhibitor to limit/prevent ischemia

A

Acute coronary syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Low-molecular weight heparins are now the drugs of first choice for the treatment and prevention of this

A

Deep venous thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Can be induced by unfractionated heparin and low-molecular weight heparin; fondaparinux will not induce but should not be used as a replacement anticoagulant as it can exacerbate the situation

A

Thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Contraindication for alteplase and most serious concern with its use

A

Intracranial hemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

If high risk for this causing acute coronary syndrome, a daily dose of aspirin may be indicated

A

Coronary heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Leading to decreased levels of VKORC1 (Vitamin K epoxide reductase complex subunit 1) This is found in ~90% of asians and is why they are more sensitive to warfarin than blacks

A

Genetic variability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

A treatment for bleeding (tranexamic acid is another), it prevents activation of plasminogen and directly inhibits plasmin

A

Amino caproicacid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Platelet derived ligand for autocrine/paracrine stimulation of aggregation via P2Y12 receptors

A

ADP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Among the best selling drugs in the world, it suppresses platelet aggregation by irreversibly blocking P2Y12 receptors

A

Clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Indication for alteplase if acute and massive, otherwise focus on limiting likelihood of more with anticoaguluants

A

Pulmonary embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Release of this GPCR ligand from endothelial cells keeps platelets in an unactivated state

A

PGI2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Sequence of letters in a general drug name that suggests blockade of P2Y12 receptors

A

-GREL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Breaks down a blood clot when bound to it, when circulating it breaks down various clotting factors unless bound by alpha2-antiplasmin

A

Plasmin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Comparative color of arterial clots due to abundance of platelets of this side of circulation; reason platelet targeting drugs are chosen for problems there

A

White

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Platelet receptors that allow the platelets to link together (aggregate), drugs that block these receptors block the final common pathway of platelet aggregation and are therefore the most effective antiplatelet drugs

A

GpIIb/IIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Dabigatran was found to be inferior to warfarin at inhibiting thromboembolism in these

A

Mechanical heart valves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Can be used to assess anticoagulation caused by dabigatran

A

Diluted thrombin time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Characteristic of both onset and offset of warfarin’s anticoagulant effects

A

Slow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Synthetic pentasaccharide, the minimum sequence needed to bind to antithrombin and inhibit factor Xa; sequence is too short to form the ternary complex with thrombin that is needed to inhibit thrombin activity

A

Fondaparinux

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Needed by clopidogrel for activation and inhibited by proton pump inhibitors; reason Prilosec media mention Plavix and vice versa

A

CYP2C19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Enzyme thought to be responsible for synthesis of platelet inhibitor PGI2 by endothelial cells; its selective sparing by low doses of aspirin is thought to explain the cardiovascular benefits of aspirin and the adverse effects associated with withdrawn drug rofecoxib

A

COX2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Procedure (abbr.) that is indication for a GpIIb/IIIa inhibitor, which is used to prevent rapid re-occlusion

A

PCI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Required for synthesis of biologically active clotting factors II, VII, IX, X, protein C, and protein S among others, and antidote for warfarin

A

Vitamin K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

When severe and uncontrolled, a relative contraindication for alteplase

A

Hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Bleeds here (e.g. hematoms) are a common manifestation of clotting factor deficiencies

A

Deep tissue

34
Q

Platelet Fc receptors bind an IgG bound to heparin and this in heparin-induced thrombocytopenia, leads to platelet activation/thrombosis and platelet removal by splenic macrophages

A

Platelet factor 4

35
Q

Dabigatran is unstable and must be stored in this type of bottle (i.e. can’t use a pill-minder) while also avoiding excess heat or cold

A

Desiccator

36
Q

Contraindication for alteplase unless has occured within past 3 hours, when it is an indication

A

Ischemic stroke

37
Q

A challenge for both heparin and warfarin, reason that frequent coagulation tests are required

A

Dosing

38
Q

Lower than 2 and the risk for thromboembolism increases in patients treated with warfarin while higher than 3 and risk of intracranial hemorrhage increases

A

INR

39
Q

Abbr. for condition treated with heparin

A

DIC

40
Q

A P2Y12 inhibitor similar to clopidogrel and competing for market share, more effective with fewer drug interactions but also causes more major bleeding

A

Prasugrel

41
Q

A nonpeptide inhibitor of GPIIb/IIIa used for acute coronary syndromes, patent recently expired

A

Tirofiban

42
Q

A mixture of long highly negatively charged polysaccharide chains isolated from bovine lung or porcine intestine, a pentasaccharide sequence randomly distributed along its length binds to antithrombin to facilitate its inhibition of factor Xa and thrombin

A

Heparin

43
Q

Risk of this can be reduced during alteplase administration by minimizing physical manipulation of the patient, avoiding subQ and IM injections, and minimizing concurrent use of anticoagulants and antiplatelet drugs

A

Bleeding

44
Q

Glycoprotein produced via recombinant DNA technonlogy that is identical in aa sequence to human tissue plasminogen activator (t-PA)

A

Alteplase

45
Q

Color of blood clots on the venous side of the circulation, consequence of fibrin mesh that forms

A

Red

46
Q

Obvious and effective treatment for bleeding

A

Blood replacement

47
Q

Had been no reliable way to monitor the degree of this for either dabigatran or rivaroxaban

A

Anti-coagulation

48
Q

Purified Fab fragments of monoclonal antibody that prevent GpIIb/IIIa receptors from binding to fibrinogen

A

Abciximab

49
Q

Blocking stenosis here is an indication for clopidogrel

A

Coronary stents

50
Q

Drug class not part of this lecture, but first-line therapy for decreasing cardiovascular disease risk via lowering of LDL-C

A

Statins

51
Q

Contraindication for alteplase

A

Aortic dissection

52
Q

PAR1 antagonist indicated for reduction of thrombotic cardiovascular events in patients with history of myocardial infarction or with peripheral arterial disease; life-threatening/fatal bleeding is a side effect that has limited its use

A

Vorapaxar

53
Q

Because predictable for both fondaparinux and low-molecular weight heparins, these agents can be self-administered at home

A

Pharmacokinetics

54
Q

A direct inhibitor of activated factor X, it therefore rapidly inhibits the generation of thrombin from prothrombin

A

Rivaroxaban

55
Q

Small peptide inhibitor of GpIIb/IIIa receptor approved for use during acute coronary syndromes and percutaneous coronary intervention

A

Epitifibatide

56
Q

Seeing this sequence of letters in a generic drug name suggests product is some sort of heparin analog

A

Parin

57
Q

Laboratory test used to monitor the anticoagulant activity of heparin; ideally kept at 1.5-2 but can be a challenge since heparin has highly variable plasma levels due to a short half-life and multiple sites of nonspecific binding, some of which can hasten its clearance

A

APTT

58
Q

Ticagrelor differs from clopidogrel by not being a prodrug and by causing this type of P2Y12 receptor block

A

Reversible

59
Q

Warfarin has a multitude of these that can influence its activity and mandates regular testing and additional testing whenever changes are made to the daily treatment regimen

A

Drug interactions

60
Q

Recently approved as a reversal agent for factor Xa inhibitors rivaroxaban and apixaban

A

Andexanetalfa

61
Q

A “T” useful for diagnosing heparin-induced thrombocytopenia; expect onset between days 5-14, after starting heparin exposure, or <= 1 day if previous heparin exposure in last 30 days

A

Timing

62
Q

Type of bleeding seen primarily at platelet counts below 10,000/microL

A

Spontaneous

63
Q

Warfarin has the potential to cause this in skin, occurs when rapid fall in protein C leads to a hypercoagulable state

A

Necrosis

64
Q

Common with platelet defects, uncommon with clotting factor defects

A

Petechiae

65
Q

Hirudin analog administered IV for the prophylaxis and treatment of thrombosis in patients with or at great risk for developing heparin-induced thrombocytopenia; classic answer but DOACs may eventually displace

A

Argatroban

66
Q

Second physiological activator of plasminogen activator degrade clotting factors, acts in fluid phase/extrasvascular compartment; was withdrawn from market but now back for treatment of pulmonary embolism needing a clot buster

A

Urokinase

67
Q

Bridging molecule between activated GpIIb/IIIa receptors on platelets

A

Fibrinogen

68
Q

Protease-activated receptor on platelet surface that is permanently activated by thrombin to promote platelet aggregation

A

PAR1

69
Q

Metabolizes the more potent S-warfarin to 7-OH-warfarin; there are numerous polymorphisms in this gene and those decreasing its activity against warfarin are more common in caucasians, increasing warfarin potency 3-5x

A

CYP2C9

70
Q

Advantage of dabigatran and rivaroxaban in comparison to warfarin

A

Rapid onset

71
Q

Potent activator of platelets; it exerts these effects by cleaving a peptide from protease activated receptors (PAR1, PAR4) ont he platelet surface, thereby allowing the ligand tethered to the GPCR to activate the receptor

A

Thrombin

72
Q

Generic ending of name for drugs that function as tissue plasminogen activators

A

Plase

73
Q

Deficiencies of these tend to manifest as deep tissue bleeding forming large subcutaneous and soft tissue hematomas, hemarthroses, may be delayed/oozing after procedures

A

Clotting factors

74
Q

Durationn of clopidogrel and aspirin effects on platelets

A

Lifetime

75
Q

When clot-bound, converted by alteplase to enzyme responsible for clot breakdown

A

Plasminogen

76
Q

The use of heparin increases the risk of one of these forming and damaging the brain or spinal cord

A

Hematoma

77
Q

A vasopressin V2 analog that can be useful for treating VWD and hemophilia, it promotes release of vWF and factor VII

A

Desmopressin

78
Q

A synthetic peptide similar to leech anticoagulant hirudin, it is a direct inhibitor of thrombin, but class as a whole has had limited use since must be administered IV and much more expensive than heparin

A

Bivalirudin

79
Q

Aspirin has this for ischemic strokes, transient ischemic attaacks, stable and unstable angina and MI among others

A

Proven efficacy

80
Q

Suppresses platelet aggregation via uncertain mechanism (PDE inhibitor), synergizes with aspirin and used in combination to prevent recurrent ischemic stroke in patients with TIA or past stroke

A

Dipyridamole

CPR Wolff Puzzles (1 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions